[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/main/docs/Risk/index.md) >> Individual ID:PBN__Risk_2085 

# __Lack of preexisting immunities__

## Category to which it belongs

* [The challenges include increased domestic violence, lack of understanding of disease spread, limitations in epidemiological models, and inadequate vaccine distribution.](https://github.com/mm80843/T3.5/blob/main/docs/PBNCategory/PBN__PBNCategory_103.md)

## Closest similar item

* [Lack of immunity](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2731.md)
* [Lack of immunity in the population](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2685.md)
* [Lack of vaccines and agent-specific drugs](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1528.md)
* [Lack of vaccine or cure](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1733.md)
* [Lack of drugs and vaccines](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1341.md)
* [Lack of covid-19 vaccine](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2277.md)
* [Lack of herd immunity](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2612.md)
* [Inadequate vaccine efficacy](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1888.md)
* [Vaccine availability, vaccine hesitancy](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3118.md)
* [Lack of knowledge about the virus, treatments, and vaccines](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2879.md)

## Description of the risk

Lack of immunity to Covid-19 in the general population

## Is the risk affecting GBN scales

* [Yes](https://github.com/mm80843/T3.5/blob/main/docs/RiskGBN/PBN__RiskGBN_1.md)

## Type of the risk

* [Physical](https://github.com/mm80843/T3.5/blob/main/docs/RiskHealth/PBN__RiskHealth_0.md)

## Type of impact of the risk (according to ISO37100)

* [Community infrastructures](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Purpose_9.md)

## Type of purpose of the risk (according to ISO37100)

* [Resilience](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Impact_2.md)

## Mitigations of this risk

* [Develop vaccines and promote vaccination programs](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2756.md)

## Name of the risk

Higher susceptibility to infection and increased risk of severe symptoms

## Stakeholders who can mitigate this risk

* [Governments](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_47.md)
* [Healthcare institutions](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_269.md)
* [Pharmaceutical companies](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_124.md)

## Articles mentionning the risk

* [Contextualizing the Covid-19 pandemic for a carbon-constrained world: Insights for sustainability transitions, energy justice, and research methodology](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_123.md)

## People affected by this risk

* [General population](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_9.md)

## Technologies linked to the risk

* [Vaccine development and distribution](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_1602.md)

## Property: has_RiskType

* [Technological](https://github.com/mm80843/T3.5/blob/main/docs/RiskType/PBN__RiskType_5.md)

